Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

CPSF3L anticorps (N-Term)

CPSF3L Reactivité: Humain WB, IF, IHC (p) Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN5534952
  • Antigène Voir toutes CPSF3L Anticorps
    CPSF3L (Cleavage and Polyadenylation Specific Factor 3-Like (CPSF3L))
    Épitope
    • 15
    • 8
    • 8
    • 7
    • 3
    • 2
    • 1
    • 1
    • 1
    AA 91-119, N-Term
    Reactivité
    • 31
    • 18
    • 16
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 46
    Lapin
    Clonalité
    • 46
    Polyclonal
    Conjugué
    • 15
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp CPSF3L est non-conjugé
    Application
    • 38
    • 17
    • 16
    • 16
    • 13
    • 13
    • 7
    • 6
    • 3
    • 3
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
    Purification
    This antibody is purified through a protein A column, followed by peptide affinity purification.
    Immunogène
    This CPSF3L antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 91-119 amino acids from the N-terminal region of human CPSF3L.
    Isotype
    Ig Fraction
    Top Product
    Discover our top product CPSF3L Anticorps primaire
  • Indications d'application
    For WB starting dilution is: 1:1000

    For IHC-P starting dilution is: 1:10~50

    For IF starting dilution is: 1:10~50
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    0.5 mg/mL
    Buffer
    Supplied in PBS with 0.09 % (W/V) sodium azide.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C,-20 °C
    Stockage commentaire
    Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
  • Antigène
    CPSF3L (Cleavage and Polyadenylation Specific Factor 3-Like (CPSF3L))
    Autre désignation
    CPSF3L (CPSF3L Produits)
    Synonymes
    anticorps DDBDRAFT_0204486, anticorps DDBDRAFT_0234100, anticorps DDB_0204486, anticorps DDB_0234100, anticorps int11, anticorps CPSF73L, anticorps INT11, anticorps INTS11, anticorps RC-68, anticorps RC68, anticorps 2410006F12Rik, anticorps AU044035, anticorps RGD1306841, anticorps zgc:110671, anticorps CPSF3L, anticorps DKFZp469C1432, anticorps cleavage and polyadenylation specific factor 3-like, anticorps integrator complex subunit 11, anticorps RNA-metabolising metallo-beta-lactamase domain-containing protein, anticorps microRNA 6727, anticorps CPSF3L, anticorps INTS11, anticorps ints11, anticorps Ints11, anticorps MIR6727
    Sujet
    The Integrator complex contains at least 12 subunits and associates with the C-terminal domain of RNA polymerase II large subunit (POLR2A, MIM 180660) and mediates the 3-prime end processing of small nuclear RNAs U1 (RNU1, MIM 180680) and U2 (RNU2, MIM 180690). INTS11, or CPSF3L, is the catalytic subunit of the Integrator complex (Baillat et al., 2005 [PubMed 16239144]).
    Poids moléculaire
    68 kDa
    ID gène
    54973
    UniProt
    Q5TA45
Vous êtes ici:
Support technique